DOV A MD GOLDSTEIN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DOV A MD GOLDSTEIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DOV A MD GOLDSTEIN. DOV A MD GOLDSTEIN is a Chief Financial Officer in VICURON PHARMACEUTICALS INC ($MICU) and a Director in NeuBase Therapeutics, Inc. ($OHRP) and a Director in ADMA BIOLOGICS, INC. ($ADMA) and a Director in Esperion Therapeutics, Inc. ($ESPR) and a Director in CEMPRA, INC. ($CEMP) and a CFO and Treasurer in Loxo Oncology, Inc. ($LOXO).
Address: 455 S. GULPH ROAD SUITE 305 KING OF PRUSSIA 19406 PA
Companies in which DOV A MD GOLDSTEIN is an Insider
ADMA BIOLOGICS, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DOV A MD GOLDSTEIN: Director
Holdings: 7,500 shares
Current Value: $37,500
Latest Transaction: Mar 03 2020
$ADMA Market Capitalization: $63.82M
$ADMA Previous Close: $5.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Esperion Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DOV A MD GOLDSTEIN: Director
Holdings: 5,047 shares
Current Value: $89,130
Latest Transaction: Jun 08 2018
$ESPR Market Capitalization: $454.22M
$ESPR Previous Close: $17.66
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Loxo Oncology, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DOV A MD GOLDSTEIN: CFO and Treasurer
Holdings: 65,873 shares
Current Value: $2,615,158
Latest Transaction: Apr 03 2015
$LOXO Market Capitalization: $860.18M
$LOXO Previous Close: $39.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MELINTA THERAPEUTICS, INC. /NEW/
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DOV A MD GOLDSTEIN: Director
Holdings: 99,900 shares
Current Value: $299,700
Latest Transaction: Mar 09 2017
$MLNT Market Capitalization: $151.90M
$MLNT Previous Close: $3.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NeuBase Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DOV A MD GOLDSTEIN: Director
Holdings: 22,000 shares
Current Value: $29,700
Latest Transaction: Apr 27 2021
$NBSE Market Capitalization: $48.55M
$NBSE Previous Close: $1.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
VICURON PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DOV A MD GOLDSTEIN: Chief Financial Officer
Holdings: 2,000 shares
Latest Transaction: Sep 10 2004
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of DOV A MD GOLDSTEIN
Sentiment: All, ADMA, ESPR, LOXO, MLNT, NBSE, MICU
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 27 2021 | NBSE | NeuBase Therapeuti ... | GOLDSTEIN DOV A MD | Director | Buy | P | 5.00 | 12,000 | 60,000 | 22,000 | 10 K to 22 K (+120.00 %) |
| Sep 11 2020 | OHRP | NeuBase Therapeuti ... | GOLDSTEIN DOV A MD | Director | Option Exercise | A | 8.80 | 14,634 | 128,779 | 14,634 | |
| May 04 2020 | OHRP | NeuBase Therapeuti ... | GOLDSTEIN DOV A MD | Director | Buy | P | 6.00 | 10,000 | 60,000 | 10,000 | 0 to 10 K |
| Mar 03 2020 | ADMA | ADMA BIOLOGICS, IN ... | GOLDSTEIN DOV A MD | Director | Option Exercise | A | 2.92 | 15,000 | 43,725 | 15,000 | |
| Mar 03 2020 | ADMA | ADMA BIOLOGICS, IN ... | GOLDSTEIN DOV A MD | Director | Grant | A | 0.00 | 7,500 | 0 | 7,500 | 0 to 7.5 K |
| Jul 16 2019 | OHRP | NeuBase Therapeuti ... | GOLDSTEIN DOV A MD | Director | Option Exercise | A | 5.39 | 227,330 | 1,225,309 | 227,330 | |
| Jul 16 2019 | OHRP | NeuBase Therapeuti ... | GOLDSTEIN DOV A MD | Director | Option Exercise | A | 5.39 | 227,330 | 1,225,309 | 227,330 |